Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Breast Neoplasms 29Pain, Postoperative 10Colorectal Neoplasms 10Neoplasms 8Brain Neoplasms 8Stomach Neoplasms 7Prostatic Neoplasms 6Lung Neoplasms 6Pancreatic Neoplasms 5Melanoma 5Ovarian Neoplasms 4Hemorrhage 4Head and Neck Neoplasms 4Agnosia 4Rectal Neoplasms 3Neurotoxicity Syndromes 3Nasopharyngeal Carcinoma 3Myoma 3Multiple Endocrine Neoplasia Type 1 3Meningioma 3Lymphoma, Non-Hodgkin 3Leiomyoma 3Glioblastoma 3Delirium 3Colonic Neoplasms 3Chronic Pain 3Warts 2Uterine Cervical Neoplasms 2Stomatitis 2Skin Neoplasms 2

Interventions

Propofol 4Saline Solution 3Dexmedetomidine 3remimazolam 2Sugammadex 1Sufentanil 1Spectroscopy, Near-Infrared 1Sodium Chloride 1Ropivacaine 1Pyridostigmine Bromide 1Neuroleptanalgesia 1Nalbuphine 1Minocycline 1Midazolam 1Methylene Blue 1Ketamine 1Injections 1Ibuprofen 1Duloxetine Hydrochloride 1Control Groups 1Blood Specimen Collection 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Emergence Delirium × Sodium Chloride × Clear all
NCT05176119 2022-01-04

Nalbuphine Versus Ketamine for Prevention of Emergence Agitation After Sevoflurane in Children Undergoing Tonsillectomy

Ain Shams University

Phase 4 Completed
90 enrolled
LymphoidOther hematologic neoplasm

Emergence Delirium, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡